167 related articles for article (PubMed ID: 24091085)
21. Bradycardia related to ribavirin in four pediatric patients with Crimean-Congo hemorrhagic fever.
Tezer H; Ozkaya Parlakay A; Gülhan B; Cetin I
Vector Borne Zoonotic Dis; 2014 Jun; 14(6):464-5. PubMed ID: 24745325
[TBL] [Abstract][Full Text] [Related]
22. Nosocomial outbreak of Crimean-Congo haemorrhagic fever.
Naderi HR; Sarvghad MR; Bojdy A; Hadizadeh MR; Sadeghi R; Sheybani F
Epidemiol Infect; 2011 Jun; 139(6):862-6. PubMed ID: 20800007
[TBL] [Abstract][Full Text] [Related]
23. An Unusual Case of Crimean Congo Hemorrhagic Fever: Prolonged Bleeding with Successful Recovery.
Hussain Q; Shaikh BH; Bhutto AR; Sohaib M
J Coll Physicians Surg Pak; 2016 Feb; 26(2):151-3. PubMed ID: 26876406
[TBL] [Abstract][Full Text] [Related]
24. Crimean-Congo hemorrhagic fever.
Vorou R; Pierroutsakos IN; Maltezou HC
Curr Opin Infect Dis; 2007 Oct; 20(5):495-500. PubMed ID: 17762783
[TBL] [Abstract][Full Text] [Related]
25. The role of ribavirin in the therapy of Crimean-Congo hemorrhagic fever: early use is promising.
Tasdelen Fisgin N; Ergonul O; Doganci L; Tulek N
Eur J Clin Microbiol Infect Dis; 2009 Aug; 28(8):929-33. PubMed ID: 19301047
[TBL] [Abstract][Full Text] [Related]
26. [Crimean-Congo hemorrhagic fever: basics for general practitioners].
Flusin O; Iseni F; Rodrigues R; Paranhos-Baccalà G; Crance JM; Marianneau P; Bouloy M; Peyrefitte CN
Med Trop (Mars); 2010 Dec; 70(5-6):429-38. PubMed ID: 21520641
[TBL] [Abstract][Full Text] [Related]
27. A case of Crimean-congo hemorrhagic fever with pleural effusion.
Tanir G; Tuygun N; Balaban I; Doksöz O
Jpn J Infect Dis; 2009 Jan; 62(1):70-2. PubMed ID: 19168966
[TBL] [Abstract][Full Text] [Related]
28. Possible horizontal transmission of crimean-congo hemorrhagic Fever virus from a mother to her child.
Saijo M; Tang Q; Shimayi B; Han L; Zhang Y; Asiguma M; Tianshu D; Maeda A; Kurane I; Morikawa S
Jpn J Infect Dis; 2004 Apr; 57(2):55-7. PubMed ID: 15118210
[TBL] [Abstract][Full Text] [Related]
29. Erythema nodosum in the course of Crimean-Congo haemorrhagic fever.
Bijani B; Mardani M; Toosi P
Trop Doct; 2010 Apr; 40(2):123-4. PubMed ID: 20305115
[TBL] [Abstract][Full Text] [Related]
30. Identification of the crucial parameters regarding the efficacy of ribavirin therapy in Crimean-Congo haemorrhagic fever (CCHF) patients: a systematic review and meta-analysis.
Arab-Bafrani Z; Jabbari A; Mostakhdem Hashemi M; Arabzadeh AM; Gilanipour A; Mousavi E
J Antimicrob Chemother; 2019 Dec; 74(12):3432-3439. PubMed ID: 31369086
[TBL] [Abstract][Full Text] [Related]
31. Crimean Congo hemorrhagic fever in Hazara division.
Malik S; Diju IU; Naz F
J Ayub Med Coll Abbottabad; 2011; 23(2):90-2. PubMed ID: 24800352
[TBL] [Abstract][Full Text] [Related]
32. A preliminary study to evaluate the effect of intravenous ribavirin treatment on survival rates in Crimean-Congo hemorrhagic fever.
Cevik MA; Elaldi N; Akinci E; Ongürü P; Erbay A; Buzgan T; Uzun R; Kubar A; Bodur H
J Infect; 2008 Oct; 57(4):350-1. PubMed ID: 18722669
[No Abstract] [Full Text] [Related]
33. Ribavirin treatment for Crimean-Congo hemorrhagic fever.
Leblebicioglu H
Jpn J Infect Dis; 2009 Nov; 62(6):485-6; author reply 486. PubMed ID: 20058332
[No Abstract] [Full Text] [Related]
34. EPIDEMIOLOGY, CLINICAL AND LABORATORY FEATURES OF CRIMEAN-CONGO HEMORRHAGIC FEVER IN GEORGIA.
Vashakidze E; Mikadze I
Georgian Med News; 2015 Oct; (247):54-8. PubMed ID: 26483375
[TBL] [Abstract][Full Text] [Related]
35. Bradycardia seen in children with Crimean-Congo hemorrhagic fever.
Oflaz MB; Kucukdurmaz Z; Guven AS; Karapinar H; Kaya A; Sancakdar E; Deveci K; Gul I; Erdem A; Cevit O; Icagasioglu FD
Vector Borne Zoonotic Dis; 2013 Nov; 13(11):807-11. PubMed ID: 24107209
[TBL] [Abstract][Full Text] [Related]
36. Systematic Review and Meta-analysis of Postexposure Prophylaxis for Crimean-Congo Hemorrhagic Fever Virus among Healthcare Workers.
Ergönül Ö; Keske Ş; Çeldir MG; Kara İA; Pshenichnaya N; Abuova G; Blumberg L; Gönen M
Emerg Infect Dis; 2018 Sep; 24(9):1642-1648. PubMed ID: 30124196
[TBL] [Abstract][Full Text] [Related]
37. DEBATE (see Elaldi N et al, Efficacy of oral ribavirin treatment in Crimean-Congo haemorrhagic fever: a quasi-experimental study from Turkey. Journal of Infection 2009; 58: 238-244): Biases and misinterpretation in the assessment of the efficacy of oral ribavirin in the treatment of Crimean-Congo hemorrhagic fever.
Ergonul O
J Infect; 2009 Oct; 59(4):284-6; author reply 286-9. PubMed ID: 19699762
[No Abstract] [Full Text] [Related]
38. Current treatment of Crimean-Congo hemorrhagic fever in children.
Mardani M; Rahnavardi M; Sharifi-Mood B
Expert Rev Anti Infect Ther; 2010 Aug; 8(8):911-8. PubMed ID: 20695747
[TBL] [Abstract][Full Text] [Related]
39. Concurrent Crimean-Congo hemorrhagic fever and visceral leishmaniasis in a Turkish girl.
Tezer H; Tavil B; Sucaklı IA; Korukluoğlu G; Uyar Y; Dinçer E; Tunç B; Özkul A
Vector Borne Zoonotic Dis; 2011 Jun; 11(6):743-5. PubMed ID: 21083375
[TBL] [Abstract][Full Text] [Related]
40. Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisited.
Ergonul O; Celikbas A; Baykam N; Eren S; Dokuzoguz B
Clin Microbiol Infect; 2006 Jun; 12(6):551-4. PubMed ID: 16700704
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
